Decheng Capital LLC Beyond Spring Inc. Call Options Transaction History
Decheng Capital LLC
- $356 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BYSI
# of Institutions
20Shares Held
5.28MCall Options Held
200Put Options Held
0-
Black Rock Inc. New York, NY215KShares$527,6190.0% of portfolio
-
Ubs Group Ag40.9KShares$100,1580.0% of portfolio
-
Tanaka Capital Management Inc New York, NY26.3KShares$64,4250.09% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$59,7010.0% of portfolio
-
Two Sigma Securities, LLC New York, NY22KShares$53,9750.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $95.4M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...